☆ 4.6 Letter

Durable response to first-line nivolumab in a patient with oligometastatic PD-L1 positive nasopharyngeal cancer

ORAL ONCOLOGY (2018)

Journal

ORAL ONCOLOGY

Volume 87, Issue -, Pages 204-206

Publisher

ELSEVIER SCIENCE BV

DOI: 10.1016/j.oraloncology.2018.10.019

Keywords

Nasopharyngeal cancer; PDL1; Nivolumab; Radiotherapy; First-line; Oligometastatic disease; Platinum-induced neurotoxicity

Categories

Oncology Dentistry, Oral Surgery & Medicine

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.